Class II · Moderate risk Ongoing
TopCare health
Reason Presence of foreign substance: small metallic particles in chewable tablets.
Lithium Carbonate Extended-Release Tablets
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
What was recalled
Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-1300-01
- Recalling firm
- Cardinal Healthcare
- Origin
- OH, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0189-2024
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Carbonate recalls
See all
Class II · Moderate risk Ongoing
TopCare health
Reason Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk Ongoing
EQUALINE ultra strength
Reason Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk Ongoing
EQUALINE extra strength
Reason Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk Ongoing
GOODSENSE Ultra Strength
Reason Presence of foreign substance: small metallic particles in chewable tablets.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.